Certified by Founder Lodge
Manifold Bio
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $40,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
A next-generation protein therapeutics company pioneering an in vivo biologics design platform. By redesigning in vivo measurement to be available from day one, Manifold Bio has an advantage
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 14 ,2022 | Series A | $40,000,000 |
Playground Global
Section 32
Horizons Ventures
Triatomic Capital
Fifty Years
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Avant Genomics | $3,000,000 | (May 14, 2026)
Vector 👻 | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
